Mindfulness-based psychoeducation for schizophrenia patients
The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours
This study is testing a mindfulness program to see if it can help people with schizophrenia feel better about themselves and adopt healthier habits.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Kastamonu University Academic / other |
| Locations | 1 site (Kastamonu, Central) |
| Trial ID | NCT06882538 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of a mindfulness-based psychoeducation program on individuals diagnosed with schizophrenia, focusing on reducing internalized stigma and promoting healthy lifestyle behaviors. The program will be administered individually to patients registered at the Kastamonu Community Mental Health Centre over a six-week period. Participants will be assessed before and after the intervention using various scales to measure stigma and lifestyle changes. The study employs a pre-test-post-test design with control and experimental groups to evaluate the effectiveness of the intervention.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with schizophrenia who are registered and actively participating in treatment at the Community Mental Health Centre.
Not a fit: Patients who have not been diagnosed with schizophrenia or those unwilling to participate in the study will not benefit.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and self-perception of patients with schizophrenia.
How similar studies have performed: While there have been interventional studies on stigma in schizophrenia, this specific approach combining mindfulness and psychoeducation is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Having been diagnosed with schizophrenia 2. TRSM registered and continuing 3. Acceptance to work and training Exclusion Criteria: 1. Have not been diagnosed with schizophrenia 2. If he/she does not agree to participate in the study 3. If not registered with TRSM
Where this trial is running
Kastamonu, Central
- Kastamonu Community Mental Health Centre — Kastamonu, Central, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Havva K KAÇAN, ASSOCIATE PROFESSOR DOCTOR — Kastamonu University
- Study coordinator: Havva K KAÇAN, ASSOCIATE PROFESSOR DOCTOR
- Email: hkacan@kastamonu.edu.tr
- Phone: 05057753893
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.